Article Per Year (5 Year)
p-Index From 2021 - 2026
0.61
P-Index
This Author published in this journals
All Journal Farmaka Jurnal An-Najat: Jurnal Ilmu Farmasi dan Kesehatan Obat: Jurnal Riset Ilmu Farmasi dan Kesehatan
Raden Bayu Indradi
Unknown Affiliation
Biochemistry, Genetics & Molecular Biology Chemistry Dentistry Health Professions Immunology & microbiology Materials Science & Nanotechnology Medicine & Pharmacology Nursing Public Health Veterinary

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

 1 
REVIEW: PROFIL FITOKIMIA DAN AKTIVITAS FARMAKOLOGI BALUNTAS (Pluchea indica L.) M IRFAN FITRIANSYAH; Raden Bayu Indradi
Farmaka Vol 16, No 2 (2018): Suplemen Agustus
Publisher : Fakultas Farmasi, Universitas Padjadjaran

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (446.681 KB) | DOI: 10.24198/jf.v16i2.17554

Abstract

Tanaman beluntas  (Pluchea indica L.)  merupakan tanaman dari suku Asteraceae yang banyak dikenal di beberapa daerah Indonesia. Tanaman beluntas digunakan sebagai obat tradisional dengan memanfaatkan berbagai bagian tanaman, antara lain bunga, daun, batang, hingga akar. Secara empirik tanaman beluntas digunakan untuk pengobatan inflamasi, antidiuretik, antibakteri, dan analgesik. Tanaman beluntas memiliki  banyak kandungan senyawa kimia, yaitu mengandung flavonoid, tanin dan minyak atsiri. Berdasarkan beberapa penelitian diketahui tanaman beluntas memiliki aktivitas farmakologi seperti anti-oksidan, anti-inflamasi dan analgesik. Potensi aktivitas farmakologi serta informasi kandungan senyawa dari tanaman beluntas perlu digali dan dikaji lebih lanjut untuk pengembangan serta pemanfaatan beluntas sebagai obat herbal.Kata kunci : Aktivitas Farmakologi, Deskripsi tanaman dan Potensi Tanaman
Evaluasi Pemenuhan Aspek Cara Distribusi Obat yang Baik (CDOB) pada Pedagang Besar Farmasi (PBF) dan PBF Cabang di Bawah Pengawasan Balai Besar POM di Bandung Periode Januari – Juli 2024 Asyifa Mughnitiyas; Raden Bayu Indradi
An-Najat Vol. 3 No. 1 (2025): An-Najat: Jurnal Ilmu Farmasi dan Kesehatan
Publisher : STIKes Ibnu Sina Ajibarang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59841/an-najat.v3i1.2322

Abstract

Cara Distribusi Obat yang Baik (CDOB) is a way of distributing/distributing drugs and/or medicinal ingredients with the aim of ensuring quality along the distribution line according to the requirements and purposes of its use. In the drug distribution process, Badan Pengawas Obat dan Makanan (BPOM) will supervise the product and distribution channels. If PBF has applied the CDOB aspect well, the PBF will get a CDOB certificate which is a valid document and can be used as proof that the PBF has met the requirements to distribute pharmaceutical products. The research was conducted using a qualitative method that is descriptive, a method of data collection by straightening documents obtained from the Certification section of the Balai Besar POM (BBPOM) in Bandung. The results of the study showed that PBF and PBF branches under the supervision of BBPOM in Bandung in the period of January - July 2024 did not 100% meet the CDOB aspect, from 69 PBF there were 6 PBF (8.70%) that had met > 80% of the CDOB aspect, 39 PBF (56.5%) that had met 50 - 79% of the CDOB aspect, and there were 24 PBF (34.8%) that met < 50% of CDOB aspects, from the 12 aspects of CDOB aspects of Building and Equipment had the highest percentage which was 10% with a total of 66 PBF out of 69 PBF or around 95.65% PBF did not meet the standards of Building and Equipment aspects.
Analisis Permasalahan Pelaku Usaha dalam Proses Pemenuhan Komitmen Registrasi Pangan Olahan Risiko Menengah Rendah Ira Novianty Lestari; Raden Bayu Indradi; Nurul Wahyu Wadarsih
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 2 No. 3 (2024): May : OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v2i3.417

Abstract

Before processed food is marketed in Indonesia, business actors must register the food to obtain a distribution permit. For medium to low risk processed food, a distribution permit must be obtained by obtaining a Business Activity Support Business Permit (PB-UMKU) with a Certificate of Fulfillment of Processed Food Commitments. This article will discuss the difficulties faced by industry players in this process and explain the fulfillment of registration commitments for low-medium processed food. This research method is a literature search using a legislative approach in processing processed food registration, and to collect field research questions, a survey of business actors was carried out during the technical guidance activity "Fulfilling Commitments for Registration of Processed Food with Medium Low Risk". The results of the analysis show that there are three critical points that business actors need to pay attention to in the process of fulfilling commitments, namely suitability of product data, suitability of composition, and suitability of label design. Errors in selecting packaging due to non-compliance with the original packaging requirements provided are the most frequently encountered problems. Apart from that, business actors often do not upload important documents such as the Health Certificate/Free Sale Certificate, which is the main required document in the import product registration process. Other errors include selecting an incorrect food category, which results in non-compliance with applicable regulations and cancellation of registration commitments.
Studi Dampak Poison Control Centre di Beberapa Negara dan Potensi Penerapannya di Indonesia Aisyah Safira Mulia; Raden Bayu Indradi; Fairuz Murti
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 2 No. 4 (2024): Juli : OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v2i4.572

Abstract

According to PUSAKOM in 2022, the prevalence of poisoning in Indonesia in 2021 was 5,921 cases, which is the total number of cases from various categories of causes of poisoning. It was found that 998 cases (17%) were cases of drug and food poisoning, and the other 4,923 cases (83%) were not cases of drug and food poisoning. Poisoning is a condition where psychoactive substances enter which cause disturbances in consciousness, cognition, perception, effects, behavior, function and psychophysiological responses. The Poison Control Center (PCC) was established to assist in the prevention, diagnosis and management of toxicity cases. PCC contributes to various sectors, including education in the field of toxicology and public education, public health by reducing the number of poisoning cases, to the economy by producing a high cost-benefit ratio. However, PCC has not yet been formed in Indonesia. Therefore, there is a need to study the impact of the Poison Control Center and its potential when implemented in Indonesia. The analysis was carried out using article and literature review methods. The results obtained from the review show that the Poison Control Center has enormous potential when implemented in Indonesia from an economic, educational, and health perspective.
Co-Authors Aisyah Safira Mulia Asyifa Mughnitiyas Fairuz Murti Ira Novianty Lestari M IRFAN FITRIANSYAH Nurul Wahyu Wadarsih